Crescent Capital BDC, Inc. (NASDAQ:CCAP) Declares $0.42 Quarterly Dividend

Key Points

• Crescent Capital BDC, Inc. has declared a quarterly dividend of $0.42 per share, with an ex-dividend date set for September 30th and a payment date of October 15th.
• The company's current dividend payout ratio stands at 97.7%, indicating that while dividends are currently covered by earnings, future sustainability could be at risk if earnings decline.
• Crescent Capital BDC reported an earnings per share (EPS) of $0.46 for the quarter, meeting analyst expectations and showing a net margin of 26.20% alongside a revenue of $42.99 million.

Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) announced a quarterly dividend on Thursday, August 14th, Wall Street Journal reports. Shareholders of record on Tuesday, September 30th will be given a dividend of 0.42 per share on Wednesday, October 15th. This represents a c) annualized dividend and a yield of 11.0%. The ex-dividend date is Tuesday, September 30th.

Crescent Capital BDC has a dividend payout ratio of 97.7% meaning its dividend is currently covered by earnings, but may not be in the future if the company's earnings fall.

Crescent Capital BDC Stock Performance

NASDAQ:CCAP traded up $0.49 during trading hours on Thursday, hitting $15.24. 300,742 shares of the company traded hands, compared to its average volume of 186,717. Crescent Capital BDC has a twelve month low of $13.54 and a twelve month high of $20.19. The stock has a market capitalization of $564.79 million, a price-to-earnings ratio of 11.37 and a beta of 0.55. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 1.24. The firm has a 50-day moving average of $14.47 and a 200 day moving average of $16.12.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last announced its earnings results on Wednesday, August 13th. The company reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. Crescent Capital BDC had a net margin of 26.20% and a return on equity of 11.10%. The firm had revenue of $42.99 million for the quarter, compared to the consensus estimate of $42.52 million. On average, analysts forecast that Crescent Capital BDC will post 2.09 EPS for the current year.

Institutional Investors Weigh In On Crescent Capital BDC

Large investors have recently bought and sold shares of the company. HighTower Advisors LLC raised its stake in shares of Crescent Capital BDC by 0.5% in the first quarter. HighTower Advisors LLC now owns 137,366 shares of the company's stock valued at $2,352,000 after acquiring an additional 702 shares in the last quarter. Ieq Capital LLC grew its holdings in shares of Crescent Capital BDC by 3.5% during the first quarter. Ieq Capital LLC now owns 23,518 shares of the company's stock worth $403,000 after purchasing an additional 793 shares during the last quarter. Confluence Investment Management LLC grew its holdings in shares of Crescent Capital BDC by 1.3% during the second quarter. Confluence Investment Management LLC now owns 76,061 shares of the company's stock worth $1,072,000 after buying an additional 1,009 shares during the last quarter. Wells Fargo & Company MN grew its holdings in shares of Crescent Capital BDC by 0.5% during the fourth quarter. Wells Fargo & Company MN now owns 253,182 shares of the company's stock worth $4,866,000 after buying an additional 1,210 shares during the last quarter. Finally, Barclays PLC grew its holdings in shares of Crescent Capital BDC by 1.8% during the fourth quarter. Barclays PLC now owns 116,111 shares of the company's stock worth $2,232,000 after buying an additional 2,085 shares during the last quarter. 49.46% of the stock is currently owned by hedge funds and other institutional investors.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.